A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance

Alternative splicing (AS) has been shown to participate in prostate cancer (PCa) development and progression; however, a link between AS and PCa health disparities has been largely unexplored. Here we report on the cloning of a novel splice variant of FGFR3 that is preferentially expressed in Africa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Cancer Res
Egile Nagusiak: Olender, Jacqueline, Wang, Bi-Dar, Ching, Travers, Garmire, Lana X., Garofano, Kaitlin, Ji, Youngmi, Knox, Tessa, Latham, Patricia, Nguyen, Kenneth, Rhim, Johng, Lee, Norman H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6886680/
https://ncbi.nlm.nih.gov/pubmed/31266816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0415
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak